Olanzapine Improves Cachexia in a Breast Cancer Patient under Home Hospice Care

Abstract

Get full access to this article

View all access options for this article.

References

Tsutsui

: Implementation process and challenges for the community-based integrated care system in Japan. Int J Integr Care, 2014; 14:e002.

Fearon

, Strasser

, Anker

, et al.: Definition and classification of cancer cachexia: An international consensus. Lancet Oncol, 2011; 12:489–495.

Bymaster

, Calligaro

, Falcone

, et al.: Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology, 1996; 14:87–96.

Yavuzsen

, Davis

, Walsh

, et al.: Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol, 2005; 23:8500–8511.

Hamauchi

, Furuse

, Takano

, et al.: A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer, 2019; 125:4294–4302.

Tagami

, Kashiwase

, Yokoyama

, et al.: The atypical antipsychotic, olanzapine, potentiates ghrelin-induced receptor signaling: An in vitro study with cells expressing cloned human growth hormone secretagogue receptor. Neuropeptides, 2016; 58:93–101.

Navari

, Pywell

, Le-Rademacher

, et al.: Olanzapine for the treatment of advanced cancer-related chronic nausea and/or vomiting: A randomized pilot trial. JAMA Oncol, 2020; 6:895–899.